BEUDAMED
    FDA Adverse Event Other Summary report: N

    GELSYN 3

    MDR report key: 19477167 · Received June 5, 2024

    Report

    Report Number
    MW5155787
    Event Type
    Other
    Date Received
    June 5, 2024
    Report Date
    June 3, 2024
    Manufacturer
    IBSA FARMACEUTICI ITALIA SRL
    Product Code
    MOZ
    Report Source
    Voluntary report
    Reporter Location
    IL, US
    Reporter Occupation
    UNKNOWN
    Health Professional
    *

    Narratives

    Description of Event or Problem · 0

    THE OV STATED THAT SHE WAS HAVING DISCOMFORT AND MORE PAIN SINCE DOING TWO SERIES OF GELSYN. THE PATIENT STATED THAT SHE HAS DONE MUCH BETTER IN THE PAST WITH NONPREFERRED DRUG HYALGAN AE-46643 REPORTED BY HEALTH CARE PERSONNEL AND CONSENTED TO FOLLOW UP.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2320092 GELSYN 3 ACID, HYALURONIC, INTRAARTICULAR MOZ IBSA FARMACEUTICI ITALIA SRL

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Unknown